Track topics on Twitter Track topics that are important to you
Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Company was device oriented heat-based treatment systems. The Company was renamed Celsion Corporation and listed on the American Stock Exchange under the symbol CLN, in the mid 1990's. At that time, Celsion focused its efforts on expanding the Company's research portfolio and licensed technologies for the treatment of Benign Prostatic Hyperplasia (BPH), breast cancer and heat activated drug and gene delivery systems. In 2001, Celsion determined that the greatest potential for long term shareholder value was in the Company's heat activated liposomal drug delivery system and focused its resources on obtaining approval for, commercializing and monetizing its BPH technology. The BPH product has been approved by the FDA and is being marketed as the Prolieve Thermodilatation® system by Celsion's exclusive distributor Boston Scientific Corporation. Under the distribution agreement Boston Scientific has a five year (expiring in February 2009) option to purchase the Prolieve® assets for $60 million. The funds generated to date through the commercialization of Prolieve have been used to develop the company's first drug ThermoDox™ (doxorubicin encapsulated in the company's heat activated liposome) to treat cancer. Celsion is currently engaged in two Phase I dose escalation studies for the treatment of liver cancer and breast cancer patients with loco-regional recurring chest wall cancer.
10220-L Old Columbia Rd
United States of America
http://dailystocktracker.com/register/ Celsion On Thursday, shares in Lawrenceville, New Jerseyheadquartered Celsion Corp. recorded a trading volume of 3.11 million shares, which was higher than...
Celsion Corp. (heat-activated liposomal therapies for cancer) netted $6.1mm in a registered direct offering of 2.64mm common shares at $2.50 (a 31% discount). Proceeds will support an ongoing Phase II...
- Leading Experts to Discuss Clinical Programs in Primary Liver Cancer and Ovarian Cancer LAWRENCEVILLE, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology develo...
Celsion Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Celsion Corporation Mergers Acquisitions MA, Partnerships Alliances and Investments re...
Life Sciences Jobs ...
Life Sciences Jobs ...
Celsion is dedicated to the development and commercialization of innovative oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat-...
Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Co...
We have published hundreds of Celsion news stories on BioPortfolio along with dozens of Celsion Clinical Trials and PubMed Articles about Celsion for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celsion Companies in our database. You can also find out about relevant Celsion Drugs and Medications on this site too.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...
Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...